Skip to main content
. 2024 Apr 16;28:123. doi: 10.1186/s13054-024-04911-5

Fig. 1.

Fig. 1

Forest plots of aOR showing clinical cure rate (a), microbiological failure rate (b), resistance occurrence (c), and mortality rate (d) in critically ill patients attaining aggressive vs. conservative PK/PD targets of beta-lactams